PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Analyze analyst forecasts for the company and compare them with competitors.
1.17M
No peer data available for comparison.
-234.73K
No peer data available for comparison.
-1.16
No peer data available for comparison.
-30.77M
No peer data available for comparison.
-234.73K
No peer data available for comparison.
43.49M
No peer data available for comparison.
Analyze DCF forecasts for the company and compare them with competitors.
81.00K
Better than INKT's revenue of 0.00.
-92.14%
Better than INKT's revenue growth rate of -100.00%.
-51.13M
Worse than INKT's ebitda of -22.25M.
-63123.46%
Worse than INKT's ebitda margin of 100.00%.
-51.92M
Worse than INKT's ebit of -22.46M.
-64098.77%
Worse than INKT's ebit margin of 100.00%.
790.00K
Worse than INKT's depreciation of 204.62K.
76.68M
Better than INKT's total cash of 3.37M.
94662.96%
Better than INKT's cash as percentage of revenue of 100.00%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
7.95M
Worse than INKT's accounts payable of 3.91M.
9818.52%
Worse than INKT's payables as percentage of revenue of 100.00%.
-153.00K
Better than INKT's capital expenditure of -73.56K.
-188.89%
Better than INKT's capex as percentage of revenue of 100.00%.
4.99%
Worse than INKT's weighted average cost of capital (wacc) of 4.86%.
5.02%
Worse than INKT's cost of equity of 5.00%.
4.08%
Worse than INKT's cost of debt of 4.06%.
-0.23
Better than INKT's beta of 0.16.
30.07M
Worse than INKT's diluted shares outstanding of 3.77M.
1.57M
Better than INKT's total debt of 4.92M.
49.31M
Better than INKT's total equity of 28.26M.
50.89M
Better than INKT's total capital of 33.19M.
3.09%
Better than INKT's debt weighting of 14.84%.
96.91%
Better than INKT's equity weighting of 85.16%.
-51.92M
Worse than INKT's ebiat of -22.46M.
-53.46M
Worse than INKT's unlevered free cash flow of -24.24M.
2.00%
Equal to INKT's long-term growth rate of 2.00%.
No Data
No DCF data available for this metric in the selected year.
No Data
No DCF data available for this metric in the selected year.
-71.33M
Better than INKT's net debt of 347.57K.
71.33M
Better than INKT's equity value of -2.95M.
2.37
Better than INKT's equity value per share of -0.78.
View analysts' price targets and recommendations, and compare them with competitors.
$11.07
Analysts expect the stock price to increase by 521.91%.
Buy
Positive consensus among analysts.